Taken together, our results found that low tumor ALDH2 levels were linked with copy-number alteration and hyper-methylation, as well as being negatively associated with T stage and predicting poor overall survival in the HPV-unrelated HNSC. This evidence concerns the gene ALDH2 and neoplasm.